Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Baxter
Medtronic
Harvard Business School
Mallinckrodt

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Litigation Details for Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)

Docket   Start Trial Date Filed 2016-10-06
Court District Court, D. Delaware Date Terminated 2019-09-12
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Christopher J. Burke
Parties ACTAVIS ELIZABETH LLC; ACTAVIS INC.; ACTAVIS LLC; APOTEX CORP.; APOTEX INC.; ASTELLAS IRELAND CO., LTD.; ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.; ASTELLAS PHARMA INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; AUROLIFE PHARMA LLC; CADILA HEALTHCARE LTD.; LUPIN LTD.; LUPIN PHARMACEUTICALS INC.; PRINSTON PHARMACEUTICAL INC.; SANDOZ INC.; SAWAI PHARMACEUTICAL CO., LTD.; SAWAI USA INC.; WINDLAS HEALTHCARE PVT. LTD.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474; RE44,872
Attorneys Aaron M. Nelson; Alexandra M. Joyce; Alissa M. Pacchioli; Andrea L. Cheek; Andrew Russell; Anuj K. Wadhwa; Brian J. Sodikoff; Brian Sodikoff; Carol M. Pitzel Cruz; Carolyn A. Blessing; Catherine R. Gourash; Charles J. Veverka; Christine Dealy Haynes; Christopher B. Ferenc; Christopher P. Wilson; Conly S. Wythers; Daniel J Ritterbeck; Daniel M. Silver; David A. Bilson; David B. Abramowitz; Deanne M. Mazzochi; Deepro R. Mukerjee; Dennies Varughese; Dominick T. Gattuso; Emily L. Savas; Emily N. Winfield; Erin Solomon; Frederick L. Cottrell , III; Frederick R. Ball; George C. Lombardi; Jack B. Blumenfeld; Jennifer M. Coronel; Jennifer M. James; John C. Phillips , Jr.; John M. Seaman; Jonathon E. Boljesic; Joseph M. Janusz; Karen Jacobs; Kent M. Walker; Kevin P. Burke; Lance A Soderstrom; Lance A. Soderstrom; Lauren B. Cury; Loni L. Morrow; Lucinda Cole Cucuzzella; Martin S. Masar , III; Mary Matterer; Maryellen Noreika; Matthew M. Holub; Megan C. Haney; Michael J. Gaertner; Nathan Roger Hoeschen; Neelaabh Shankar; Paul W. Kalish; Pilar Gabrielle Kraman; Prajakta A. Sonalker; R. Parrish Freeman; Rachel A. Smoot; Richard L. Renck; Samantha M. Lerner; Sarah E. Delia; Stephanie Angkadjaja; Vincent L. Capuano; Vincent Li; William A. Rakoczy; William R. Zimmerman
Firms Abrams & Bayliss LLP; Duane Morris, LLP; Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Shaw Keller LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Astellas Pharma Inc. v. Actavis Elizabeth LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 action for patent infringement of United States Patent Nos. 6,346,532 (“the ’532 patent”), 7,342,117…“Notification of Certification for U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,4747,342,117 (“the ’117 patent”), 7,982,049 (“the ’049 patent”), 8,835,474 (“the ’474 patent”), and RE44,872 (“…validity and patentability of the ’532 patent. A true and correct copy of the ’532 patent is attached …(“the ’872 patent”), arising under the United States patent laws, Title 35, United States Code. This External link to document
0000-00-00 21 infringement of U.S. Patent Nos. 6,346,532 (“the ’532 patent”), 7,342,117 (“the ’117 patent”), 7,982,049 (…or more claim of U.S. Patent No. 6,346,532 (“the ’532 patent”) under the Patent Laws of the United States… to be a copy of United States Patent No. 6,346,532 (“the ’532 patent”), which indicates on its face … Paragraph IV certification as to U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474…“Notification of Certification for U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474 External link to document
0000-00-00 25 all purposes relating to United States Patent Nos. 6,346,532, 7,342,117, 7,982,049, 8,835,474, and RE44,872… certifications with respect to the 6,346,532 patent, and therefore have not been sued for …Paragraph III certifications with respect to the 6,346,532 patent, and therefore have not been sued for…Paragraph III certifications with respect to the 6,346,532 patent, and therefore have not been sued…Defendants. ) PATENT CASE SCHEDULING ORDER At Wilmington this External link to document
2017-04-24 33 Disclosures for Litigations Involving U.S. Patent Nos. 7,342,117, 7,982,049, 8,835,474 and RE44,872; and …Disclosures for Litigations Involving U.S. Patent Nos. 7,342,117, 7,982,049, 8,835,474 and RE44,872 filed… 6 October 2016 1:16-cv-00905 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
McKinsey
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.